drugset / Trial / NCT07530003

HUMSCs Combined With Col I to Third-Degree Burn Wound

NCT07530003 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds.

Timeline

Start
2026-04-06
Primary completion
2027-12-31
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject HUMSCs Cell therapy — —
Comparator bovine type I collagen Protein / enzyme biologic — —

Indications

No indication recorded.